Who are the Improving Diabetes Steering Committee?
The Improving Diabetes Steering Committee (IDSC) is a multi-disciplinary group of healthcare professionals assembled to offer evidence-based practical guidance for the use of oral type 2 diabetes medications, particularly focussing on the sodium-glucose cotransporter-2 (SGLT2) inhibitor class in people with type 2 diabetes who have been stratified by cardiovascular disease risk.
The IDSC seeks to support healthcare professionals in appropriate treatment selection for people with type 2 diabetes who are at risk of developing, or have established, cardiovascular disease and examines the role of SGLT2 inhibitor therapy for these people, from the perspective of the current UK treatment pathway.